用于预防复发性肾结石的钠-葡萄糖协同转运蛋白2抑制剂
SGLT-2 inhibitors for the prevention of recurrent nephrolithiasis.
作者信息
Sakhaee Khashayar
机构信息
Department of Internal Medicine, UT Southwestern Medical Center, Charles and Jane Pak Center for Mineral Metabolism and Clinical Research, Dallas, TX, USA.
出版信息
BMJ. 2024 Nov 7;387:q2447. doi: 10.1136/bmj.q2447.
Abstract
New study reports protective effect among people with type 2 diabetes
摘要
新研究报告2型糖尿病患者存在保护作用
相似文献
1
SGLT-2 inhibitors for the prevention of recurrent nephrolithiasis.
BMJ. 2024 Nov 7;387:q2447. doi: 10.1136/bmj.q2447.
2
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for recurrent nephrolithiasis among patients with pre-existing nephrolithiasis or gout: target trial emulation studies.
BMJ. 2024 Oct 30;387:e080035. doi: 10.1136/bmj-2024-080035.
3
SGLT2 inhibitors and nephrolithiasis risk: a meta-analysis.
Nephrol Dial Transplant. 2025 Apr 1;40(4):671-678. doi: 10.1093/ndt/gfae179.
4
Nephrolithiasis and sodium-glucose co-transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trials.
Diabetes Res Clin Pract. 2019 Sep;155:107808. doi: 10.1016/j.diabres.2019.107808. Epub 2019 Aug 8.
5
GLUcose COntrol Safety & Efficacy in type 2 DIabetes, a systematic review and NETwork meta-analysis.
PLoS One. 2019 Jun 25;14(6):e0217701. doi: 10.1371/journal.pone.0217701. eCollection 2019.
6
Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians.
Ann Intern Med. 2014 Nov 4;161(9):659-67. doi: 10.7326/M13-2908.
7
Use of Sodium-Glucose Cotransporter-2 Inhibitors in Clinical Practice for Heart Failure Prevention and Treatment: Beyond Type 2 Diabetes. A Narrative Review.
Adv Ther. 2022 Feb;39(2):845-861. doi: 10.1007/s12325-021-01989-z. Epub 2021 Dec 9.
8
Sodium glucose cotransporter (SGLT)-2 inhibitors: Do we need them for glucose-lowering, for cardiorenal protection or both?
Diabetes Obes Metab. 2019 Apr;21 Suppl 2(Suppl 2):24-33. doi: 10.1111/dom.13692.
9
SGLT-2 inhibitors in nephrotic-range proteinuria: emerging clinical evidence.
Clin Kidney J. 2022 Aug 24;16(1):52-60. doi: 10.1093/ckj/sfac189. eCollection 2023 Jan.
10
Sodium-glucose cotransporter 2 inhibitors and risk of nephrolithiasis.
Diabetologia. 2021 Jul;64(7):1563-1571. doi: 10.1007/s00125-021-05424-4. Epub 2021 Mar 13.
本文引用的文献
1
Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for recurrent nephrolithiasis among patients with pre-existing nephrolithiasis or gout: target trial emulation studies.
BMJ. 2024 Oct 30;387:e080035. doi: 10.1136/bmj-2024-080035.
2
Kidney protective mechanisms of SGLT2 inhibitors: evidence for a hemodynamic effect.
Kidney Int. 2024 Jun;105(6):1168-1172. doi: 10.1016/j.kint.2024.03.019.
3
Sodium-Glucose Cotransporter 2 Inhibitors and Nephrolithiasis Risk in Patients With Type 2 Diabetes.
JAMA Intern Med. 2024 Mar 1;184(3):265-274. doi: 10.1001/jamainternmed.2023.7660.
4
Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence.
N Engl J Med. 2023 Mar 2;388(9):781-791. doi: 10.1056/NEJMoa2209275.
5
Epidemiology of Kidney Stones.
Healthcare (Basel). 2023 Feb 2;11(3):424. doi: 10.3390/healthcare11030424.
6
Inhibition of sodium-glucose cotransporter 2 suppresses renal stone formation.
Pharmacol Res. 2022 Dec;186:106524. doi: 10.1016/j.phrs.2022.106524. Epub 2022 Oct 28.
7
Empagliflozin Changes Urine Supersaturation by Decreasing pH and Increasing Citrate.
J Am Soc Nephrol. 2022 Jun;33(6):1073-1075. doi: 10.1681/ASN.2021111515. Epub 2022 Apr 6.
8
Empagliflozin and Decreased Risk of Nephrolithiasis: A Potential New Role for SGLT2 Inhibition?
J Clin Endocrinol Metab. 2022 Jun 16;107(7):e3003-e3007. doi: 10.1210/clinem/dgac154.
9
Sodium-glucose cotransporter 2 inhibitors and risk of nephrolithiasis.
Diabetologia. 2021 Jul;64(7):1563-1571. doi: 10.1007/s00125-021-05424-4. Epub 2021 Mar 13.
10
Nephrolithiasis and sodium-glucose co-transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trials.
Diabetes Res Clin Pract. 2019 Sep;155:107808. doi: 10.1016/j.diabres.2019.107808. Epub 2019 Aug 8.
Zotero 插件